Hosted by the American Thoracic Society in conjunction with their Annual Meeting, the 2024 Respiratory Innovation Summit (RIS) will unite innovators, investors, clinicians and advocacy groups who are leading the charge to create powerful new treatments for deadly and crippling diseases of the lungs and airways. This meeting historically attracts 350+ global leaders representing all facets of the respiratory industry, including representatives from start-ups, business development, venture capital, government, academia and clinical medicine.

The 2024 RIS will take place at the Manchester Grand Hyatt San Diego from May 17^th-18^th and will feature oral and poster presentations from the following NHLBI-funded companies: Atelerix Life Sciences, Halo Biosciences, Eldec Pharmaceuticals, Fibronox, RaeSedo, Inc., and Vena Vitals. Attendees will also get a chance to hear from NHLBI Investor-in Residence Dr. Steve Flaim on May 17^th at 7 p.m. PT as he participates in the panel discussion “Perspectives on Biomedical Innovation from the Federal Government.”

For the full RIS agenda, please visit https://bit.ly/4aJsQwA. To register, please visit https://bit.ly/4aSaoS6.